Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Enantioselective titanium-catalyzed cycloadditions of thiophene-S,S-dioxides with indenes

Peilin Tian a, Viktor S. Camaraab, Margarita Valentinea, Andrew P. Tinklera, Agamemnon Crumptona and Edward A. Anderson*a
aChemistry Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK. E-mail: edward.anderson@chem.ox.ac.uk
bDepartment of Physical Chemistry, Institute of Chemistry of São Carlos, University of São Paulo, CEP 13560-970, São Carlos, Brazil

Received 16th February 2026 , Accepted 15th June 2026

First published on 23rd June 2026


Abstract

Asymmetric inverse electron-demand Diels–Alder (IEDDA) cycloadditions of thiophene S,S-dioxides (TDOs) remain largely unexplored. Here we report the development of highly enantioselective titanium-catalyzed IEDDA reactions between TDOs and indenes which enables the asymmetric construction of complex carbocyclic frameworks. In combination with TiCl2(OiPr)2, two chiral ligand classes proved capable of promoting this transformation, with BINOL-based catalysts offering optimal selectivity. The transformation exhibits broad substrate scope and high functional group tolerance, and is amenable to gram-scale synthesis; the chiral ligand can be readily recovered and recycled with no deterioration in yield or enantioselectivity. The resulting adducts are versatile synthetic intermediates, undergoing facile derivatization via reduction, esterification, Suzuki coupling, and further Diels–Alder transformations.


Introduction

Polycyclic molecules are ubiquitous throughout organic chemistry, especially in the context of the complex three-dimensional scaffolds found in bioactive natural products.1–4 For example, 6/5/6 all-carbon fused ring systems comprising one benzene ring and two saturated rings are a common structural motif that features in the cores of lucidomone, dysanbiol, ussuriedinone and hypoxylonol C (Fig. 1a).5–9 The stereocontrolled construction of such tricyclic frameworks poses a significant synthetic challenge that could be met by the implementation of stereoselective Diels–Alder reactions, due to the ability of such processes to effect the atom-economical formation of six-membered rings with control over multiple stereocenters.10–12
image file: d6sc01387b-f1.tif
Fig. 1 (a) Natural products containing a 6/5/6 all carbon fused scaffolds; (b) examples of asymmetric IEDDA/cheletropic extrusion reactions using TDOs as the diene. (c) Enantioselective titanium/BINOL-catalyzed IEDDA using TDOs and indenes (this work).

Despite the long history of Diels–Alder chemistry, the development of asymmetric inverse-electron demand Diels–Alder (IEDDA) reactions remains less established compared to normal electron-demand variants, with α-pyrones being the most explored substrate class to date.13–23 In contrast, thiophene S,S-dioxides (TDO) have received considerably less attention, despite their established utility as electron-deficient dienes for non-asymmetric IEDDA processes, in which TDOs display high reactivity due to their non-aromatic nature and intrinsically s-cis constrained diene. Upon (4+2) cycloaddition, TDOs afford sulfone-bridged adducts that readily undergo cheletropic extrusion of SO2,24,25 providing an entropic driving force that typically renders the cycloaddition irreversible. Accordingly, TDOs have been applied in cycloadditions with partners such as alkynes, alkenes and furans,26–32 and in natural product synthesis contexts for the construction of the aromatic cores of the dictyodendrins33 and the illudalane sesquiterpenes.34

Despite their promise as dienes for IEDDA chemistry, the use of TDOs in asymmetric transformations remains challenging, with few examples achieving high levels of stereocontrol in the generation of new stereogenic centers. In 2023, Aggarwal et al. described the IEDDA reaction of a TDO with a chiral bicyclic dihydrofuran (Fig. 1b), which afforded the corresponding chlorocyclohexadiene (bearing two new stereogenic centers) with excellent diastereoselectivity (>95[thin space (1/6-em)]:[thin space (1/6-em)]5 dr), although ultimately these stereocenters were ablated through aromatization.35 This transformation nonetheless served as the key step in a synthesis of the antiplatelet pharmaceutical beraprost, with the diastereoselectivity of the cycloaddition being governed by the cis-fused-nature of the bicyclic enol ether. More recently, our group reported the development of intermolecular asymmetric (4+2) cycloadditions between indoles and enantioenriched thiophene S,S-dioxides bearing an inexpensive, readily available camphorsultam sidechain, which produced tricyclic indolines as single diastereomers in high yield.36 This functional group tolerant methodology was applied to a wide range of substituted indoles, and was furthermore employed in the total synthesis of eight Strychnos alkaloids.

Both of these transformations relied on substrate stereoinduction, as catalytic asymmetric IEDDA/cheletropic extrusions of TDOs had yet to be developed. During the preparation of this manuscript, Cai et al. presented a catalytic asymmetric IEDDA between TDOs and indoles using a chiral Fe(III)/bis-oxazoline catalyst. This elegant reaction could be employed across a range of indoles bearing electron-rich and electron-poor substituents at various positions of the indole ring. However, the methodology was limited to N-alkyl indoles, and also required substitution at the indole C3 position; otherwise, a competing Michael addition of the indole to the TDO was observed.37 Here, we report a complementary asymmetric IEDDA/cheletropic extrusion of TDOs and indenes, where incorporation of an N-acyloxazolidinone moiety onto the TDO scaffold enabled coordination to a chiral titanium Lewis acid–ligand complex that is readily prepared from a common titanium salt and commercially available ligands (Fig. 1c).

Results and discussion

Our investigations began with the reaction between thiophene S,S-dioxide 1a and two equivalents of indene in the presence of TiCl2(OiPr)2 (20 mol%) and TADDOL38–42 ligand L1 (22 mol%) in toluene at −20 °C (Table 1, Entry 1). The desired cycloadduct 2a was obtained in 37% yield and 63[thin space (1/6-em)]:[thin space (1/6-em)]37 er. Encouraged by this result, we examined the influence of the aryl substituents on the TADDOL ‘arms’ (Entries 2–4).43,44 Electronic effects exerted only a minor influence on the enantioselectivity, however the introduction of the bulky 1-naphthyl group in L4 offered a pronounced improvement (Entry 4), delivering the product in 90[thin space (1/6-em)]:[thin space (1/6-em)]10 er, albeit in only 35% yield. A solvent screen (Entries 5–8) led to an improved 58% yield in chloroform while maintaining 90[thin space (1/6-em)]:[thin space (1/6-em)]10 er. The conformation of the five-membered cyclic acetal moiety in the TADDOL ligand has also been found to impact enantioselectivity,38 and we thus investigated the influence of the substituents on this ring (L5–L9, Entries 9–13). When both substituents were isopropyl (L6, Entry 10) or phenyl (L7, Entry 11), the reaction reached its highest enantioselectivity (up to 94[thin space (1/6-em)]:[thin space (1/6-em)]6 er), although the isolated yields remained modest. Hypothesizing that the moderate yield results from the relatively slow reaction rate and consequently incomplete conversion, we sought to increase the Lewis acidity of the metal center, and therefore evaluated BINOL15,17,45 as an alternative ligand. Replacing TADDOL with BINOL L10 (Entry 14) resulted in a marked enhancement of both yield (76%) and enantioselectivity (97[thin space (1/6-em)]:[thin space (1/6-em)]3 er). Several metal triflates including Yb(OTf)3,15 Mg(OTf)2[thin space (1/6-em)]46 and Eu(OTf)3[thin space (1/6-em)]47 were examined, but all afforded only moderate yields and no enantioselectivity. Given the superior performance of the Ti-based conditions, we returned to this system and screened other BINOL derivatives. Bulky substituents (L11, Entry 18 and L12, Entry 19) proved detrimental to enantioselectivity, whereas electron-withdrawing groups (3,5-CF3, L13, Entry 20) maintained high selectivity (97[thin space (1/6-em)]:[thin space (1/6-em)]3 er). Remarkably, electron-rich aryl substituents such as 3,5-dimethylphenyl (L14, Entry 21) and 4-methoxyphenyl (L15, Entry 22) delivered 2a in 77% and 85% yield respectively, both with 99[thin space (1/6-em)]:[thin space (1/6-em)]1 er. Reducing the loading to 15 mol% had minimal impact on enantioselectivity (98[thin space (1/6-em)]:[thin space (1/6-em)]2 er) but slightly reduced the yield (75%, Entry 23). Increasing the temperature to −10 °C restored the yield to 81% while maintaining 98[thin space (1/6-em)]:[thin space (1/6-em)]2 er (Entry 24). A further reduction to 10% catalyst loading led to a slight erosion in enantioselectivity and yield (Entry 25, 69%, 96[thin space (1/6-em)]:[thin space (1/6-em)]4 er). It is worth noting that molecular sieves48 were crucial for maintaining high enantioselectivity; in their absence, the enantiomeric ratio dropped dramatically.
Table 1 Optimization of asymmetric IEDDA/cheletropic extrusion of 1a and indene
a Reaction conditions: 1a (0.1 mmol), indene (0.2 mmol), Lewis acid (20 mol%), ligand (22 mol%) in solvent (1.0 mL) at −20 °C.b er Values were determined by HPLC on a chiral stationary phase.c The reaction employed 25 mol% of iPr2EtN.d 15 mol% TiCl2(OiPr)2/16.5 mol% L15.e The reaction was performed at −10 °C.f 10 mol% TiCl2(OiPr)2/11 mol% L15.
image file: d6sc01387b-u1.tif
Entry a Lewis acid Ligand Solvent Yield (%) erb
1 TiCl2(OiPr)2 L1 Toluene 37 37[thin space (1/6-em)]63
2 TiCl2(OiPr)2 L2 Toluene 41 20[thin space (1/6-em)]80
3 TiCl2(OiPr)2 L3 Toluene 27 39[thin space (1/6-em)]61
4 TiCl2(OiPr)2 L4 Toluene 35 10[thin space (1/6-em)]90
5 TiCl2(OiPr)2 L4 PhCF3 41 16[thin space (1/6-em)]84
6 TiCl2(OiPr)2 L4 CH2Cl2 52 18[thin space (1/6-em)]82
7 TiCl2(OiPr)2 L4 CHCl3 58 10[thin space (1/6-em)]90
8 TiCl2(OiPr)2 L4 Et2O 39 16[thin space (1/6-em)]84
9 TiCl2(OiPr)2 L5 CHCl3 51 8[thin space (1/6-em)]92
10 TiCl2(OiPr)2 L6 CHCl3 53 6[thin space (1/6-em)]94
11 TiCl2(OiPr)2 L7 CHCl3 41 6[thin space (1/6-em)]94
12 TiCl2(OiPr)2 L8 CHCl3 37 12[thin space (1/6-em)]88
13 TiCl2(OiPr)2 L9 CHCl3 43 10[thin space (1/6-em)]90
14 TiCl2(OiPr)2 L10 CHCl3 76 97[thin space (1/6-em)]3
15c Yb(OTf)3 L10 CHCl3 65 50[thin space (1/6-em)]50
16c Mg(OTf)2 L10 CHCl3 72 50[thin space (1/6-em)]50
17c Eu(OTf)3 L10 CHCl3 75 50[thin space (1/6-em)]50
18 TiCl2(OiPr)2 L11 CHCl3 67 67[thin space (1/6-em)]33
19 TiCl2(OiPr)2 L12 CHCl3 61 50[thin space (1/6-em)]50
20 TiCl2(OiPr)2 L13 CHCl3 83 97[thin space (1/6-em)]3
21 TiCl2(OiPr)2 L14 CHCl3 77 99[thin space (1/6-em)]1
22 TiCl2(OiPr)2 L15 CHCl3 85 99[thin space (1/6-em)]1
23d TiCl2(OiPr)2 L15 CHCl3 75 98[thin space (1/6-em)]2
24d,e TiCl2(OiPr)2 L15 CHCl3 81 98[thin space (1/6-em)]2
25f TiCl2(OiPr)2 L15 CHCl3 69 96[thin space (1/6-em)]4


Under the optimized reaction conditions (Table 1, Entry 24), we examined the scope of this transformation (Scheme 1). A series of indene derivatives bearing electron-withdrawing substituents16 were well tolerated, affording the desired products in good to excellent yields (2b–2h, 52–83%) with high enantiomeric ratios (91[thin space (1/6-em)]:[thin space (1/6-em)]9 to 98[thin space (1/6-em)]:[thin space (1/6-em)]2 er), including bromo, fluoro, cyano, trifluoromethyl, ester and nitro groups. Importantly, these substituents were accommodated regardless of their position on the indene ring (C5, C6, or C7). The transformation proved sensitive to temperature: substrates bearing weakly electron-withdrawing groups (Br, F) proceeded efficiently at −10 °C, while more electron deficient indenes (with substituents such as esters, CN, CF3 or NO2) required elevated temperatures (between room temperature and 35 °C). Electron-donating groups such as methyl and methoxy (2k, 2l) were also tolerated, affording high yields and enantiomeric ratios (54%, 91[thin space (1/6-em)]:[thin space (1/6-em)]9 er and 87%, 94[thin space (1/6-em)]:[thin space (1/6-em)]6 er respectively); the slightly reduced selectivities compared to the electron-poor substrates could be ascribed to minor levels of non-asymmetric background reaction. A sensitive boronic ester-substituted indene also performed well, affording 2m in 77% yield and 96[thin space (1/6-em)]:[thin space (1/6-em)]4 er, enabling further potential derivatization via Suzuki cross-coupling. Structurally complex substrates including phenyl-substituted indene, 3H-cyclopenta[a]naphthalene, and acenaphthylene (2n–2p) were well tolerated, furnishing the corresponding products in moderate to good yields (50–81%) and with good to excellent levels of enantioenrichment (85[thin space (1/6-em)]:[thin space (1/6-em)]15 to 98[thin space (1/6-em)]:[thin space (1/6-em)]2 er). The successful and selective reaction of acenaphthylene (98[thin space (1/6-em)]:[thin space (1/6-em)]2 er) in particular highlights the robustness of the reaction toward sterically and electronically diverse substrates. Finally, the use of other TDOs was examined: methyl substitution on the TDO scaffold afforded 2q in 54% yield and 99[thin space (1/6-em)]:[thin space (1/6-em)]1 er, while 5-bromo substitution provided 2r in 62% yield and 92[thin space (1/6-em)]:[thin space (1/6-em)]8 er. Pleasingly, a bicyclic TDO substrate reacted smoothly under the optimized conditions, delivering 2s in 52% yield with excellent enantioselectivity (99[thin space (1/6-em)]:[thin space (1/6-em)]1 er). A trisubstituted TDO was also tolerated, with 2t isolated with an excellent er of 98[thin space (1/6-em)]:[thin space (1/6-em)]2. The absolute configurations of all products were assigned by analogy to the single-crystal X-ray diffraction structure of cycloaddition product 2a (CCDC 2512830).


image file: d6sc01387b-s1.tif
Scheme 1 Substrate scope of catalytic asymmetric IEDDA between TDOs and indenes. Reaction conditions: 1a (0.10 mmol), indene (0.20 mmol), TiCl2(OiPr)2 (0.015 mmol), L15 (0.0165 mmol), 4 Å MS (50 mg), dry CHCl3 (1 mL, 0.1 M), −10 °C. aReaction performed at 35 °C. bReaction performed at 25 °C. cReaction performed at −20 °C. dTiCl2(OiPr)2 (0.025 mmol), L15 (0.0275 mmol) were used. eUsing L13 as ligand. Er values were determined by HPLC on a chiral stationary phase. The absolute configuration of 2a was determined by X-ray crystallography (CCDC 2512830).

To rationalise the stereochemical outcome, we propose the transition state model shown in Scheme 2a, in which enantioselectivity is primarily governed by steric effects. Based on established structures of Ti(IV)(BINOL) complexes,49,50 we propose an octahedral geometry where the BINOL and acyloxazolidinone adopt the depicted configuration. The oxazolidone ring is located in a relatively hindered region (proximal to one of the para-methoxylphenyl (PMP) BINOL sidechains) and the thiophene S,S-dioxide rotates to π-stack with the opposing PMP group. This arrangement blocks the ‘back’ face of the TDO (as drawn), such that the indene dienophile approaches from the front face in either an exo or endo fashion. The conformation of the oxazolidinone is such that it also protrudes towards the front face, which sterically disfavours the endo orientation of the indene. This interaction is absent in the exo orientation, which is the one that leads to the experimentally observed product.


image file: d6sc01387b-s2.tif
Scheme 2 (a) Proposed asymmetric induction model; (b) synthetic transformations; (c) investigation of other dienophile substrates.

To demonstrate the practicality of the methodology, a gram-scale synthesis of 2a was carried out (Scheme 2b), which afforded the cycloadduct in 74% yield with 98[thin space (1/6-em)]:[thin space (1/6-em)]2 er. On this larger scale, the reaction concentration could be doubled, and the catalyst loading reduced to 10 mol% without compromising the enantioselectivity. Furthermore, 88% of the ligand could be recovered by column chromatography, and the recycled ligand was successfully reused to catalyze the reaction without any loss in enantioselectivity.51 With quantities of 2a in hand, further transformations were explored: for example, 2a could be readily reduced to the allylic alcohol 3 in 89% yield, or the oxazolidinone motif could be converted into the corresponding methyl ester 4 in 83% yield under Lewis acidic promotion (CeCl3, MeOH).37 The chlorine substituent present in 2a provides additional opportunities for derivatization; for example, Suzuki–Miyaura coupling37 afforded the arylated diene 5 in 61% yield. Additionally, the diene unit in 2a underwent Diels–Alder reaction with PTAD52 (4-phenyl-1,2,4-triazoline-3,5-dione) to furnish the polycyclic bridged adduct 6 in 81% yield.

Finally, to further explore the scope of the asymmetric cycloaddition, other dienophiles were investigated (Scheme 2c). Cyclohexadiene proved a viable substrate,18 undergoing asymmetric Diels–Alder reaction with TDO 1a to give the cis-fused decalin derivative 7 in 83% yield with 82[thin space (1/6-em)]:[thin space (1/6-em)]18 er. It is interesting that cyclohexadiene was observed to act exclusively as a dienophile rather than a diene in this process, which may derive from its ability to engage in an ambimodal transition state, as found for our earlier studies with furan dienophiles.34

Inspired by our previous results on auxiliary-controlled asymmetric Diels–Alder reactions of TDOs and indoles, we further sought to develop a catalytic asymmetric variant.36 However, attempts using unsubstituted indole predominantly afforded a Michael addition product between C3 of the indole and C3 of the TDO, rather than the desired Diels–Alder adduct. Ultimately, N-methyl-3-methylindole 8 was employed as the substrate and, after a brief ligand screen, BINOL ligand L13 (substituted with 3,5-bis(trifluoromethyl) groups) was found to afford the highest enantioselectivity, providing indoline product 9 in 42% yield with 96[thin space (1/6-em)]:[thin space (1/6-em)]4 er. Notably, substitution at the N1 and C3 positions of indole is essential to suppress the undesired Michael addition pathway, which is consistent with the findings reported by Cai and co-workers.37

Conclusions

In summary, we have developed a highly enantioselective titanium-catalyzed Diels–Alder reaction of thiophene dioxides with indenes employing commercially-available BINOL derivatives as ligands, providing a broad range of polycyclic products in high yields and excellent enantioselectivities. The reaction exhibits broad substrate scope and functional group tolerance, enabling the asymmetric construction of complex carbocyclic frameworks. The practicality of the methodology was demonstrated by gram-scale synthesis and efficient ligand recycling. Furthermore, the resulting products could be readily diversified through reduction, esterification, Suzuki cross coupling, and Diels–Alder chemistry, and the reaction itself could be expanded to encompass cyclohexadiene and indole derivatives as dienophiles. Overall, this work provides a new catalytic platform for asymmetric inverse electron-demand Diels–Alder reactions based on underexplored TDOs, highlighting the untapped potential of this heterocycle in asymmetric synthesis.

Author contributions

P. T., V. S. and E. A. conceptualised the project. P. T., V. S., M. V. and A. P. carried out the investigation and developed the methodology. A. C. acquired the X-ray crystal structures of 1a and 2a. All authors conducted the formal analysis and curated the data. E. A. and P. T. supervised the project. E. A. and P. T wrote the original draft and edited the manuscript.

Conflicts of interest

There are no conflicts to declare.

Data availability

CCDC 2512830 and 2512831 contain the supplementary crystallographic data for this paper.53a,b

The data supporting this article has been included as part of the supplementary information (SI). Supplementary information: experimental procedures, NMR data and crystallographic data. See DOI: https://doi.org/10.1039/d6sc01387b.

Acknowledgements

E. A. A. and P. T. thank the EPSRC for support (EP/X028674/1). V. S. C. thanks the São Paulo Research Foundation (FAPESP) for financial support (2024/07727-8). M. V. thanks the EPSRC for a studentship.

Notes and references

  1. P. S. Baran, J. Am. Chem. Soc., 2018, 140, 4751–4755 CrossRef CAS PubMed.
  2. Y. Stöckl, T. Fellmeth, F. Bauer, B. Wank, W. Frey, B. Claasen, A. Zens, A. Köhn and S. Laschat, Eur. J. Org Chem., 2022, e202101416 CrossRef.
  3. C. G. Zhao, Z. Q. Ye, Z. X. Ma, S. A. Wildman, S. A. Blaszczyk, L. H. Hu, I. A. Guizei and W. P. Tang, Nat. Commun., 2019, 10, 4015 CrossRef PubMed.
  4. S. P. Yin, Z. Liu, J. J. Shen, Y. W. Xia, W. H. Wang, P. Y. Gui, Q. Jia, K. Kachanuban, W. M. Zhu and P. Fu, Nat. Commun., 2022, 13, 5169 CrossRef CAS PubMed.
  5. X. Z. Liao, R. Wang, X. Wang and G. Li, Nat. Commun., 2024, 15, 2647 CrossRef CAS PubMed.
  6. X. Liang, H. N. Jiang, J. T. Yang, Y. J. Duan, K. Wei and Y. R. Yang, Org. Lett., 2025, 27, 10619–10624 CrossRef CAS PubMed.
  7. Z. Xu, W. Peng, J. Huang, J. Shen, J. J. Guo and A. Hu, Nat. Commun., 2024, 15, 9748 CrossRef CAS PubMed.
  8. W. H. Jiao, J. X. Li, H. Y. Liu, X. C. Luo, T. Y. Hu, G. H. Shi, D. D. Xie, H. F. Chen, B. H. Cheng and H. W. Lin, Org. Lett., 2023, 25, 6391–6395 CrossRef CAS PubMed.
  9. M. Konya, K. Shimoyama, S. Arima, T. Fukuda, R. Uchida, H. Tomoda and T. Nagamitsu, Org. Lett., 2020, 22, 5131–5134 CrossRef CAS PubMed.
  10. K. C. Nicolaou, S. A. Snyder, T. Montagnon and G. Vassilikogiannakis, Angew. Chem., Int. Ed., 2002, 41, 1668–1698 CrossRef CAS PubMed.
  11. A. Rana, A. Mishra and S. K. Awasthi, RSC Adv., 2025, 15, 4496–4525 RSC.
  12. A. A. Sara, Um-E.-. Farwa, A. Saeed and M. Kalesse, Synthesis, 2022, 54, 975–998 CrossRef CAS.
  13. C. J. F. Cole, L. Fuentes and S. A. Snyder, Chem. Sci., 2020, 11, 2175–2180 RSC.
  14. G. H. Huang, R. Guillot, C. Kouklovsky, B. Maryasin and A. de la Torre, Angew. Chem., Int. Ed., 2022, 61, e202208185 CrossRef CAS PubMed.
  15. X. W. Liang, Y. L. Zhao, X. G. Si, M. M. Xu, J. H. Tan, Z. M. Zhang, C. G. Zheng, C. Zheng and Q. Cai, Angew. Chem., Int. Ed., 2019, 58, 14562–14567 CrossRef CAS PubMed.
  16. Y. Lu, M. M. Xu, Z. M. Zhang, J. Zhang and Q. Cai, Angew. Chem., Int. Ed., 2021, 60, 26610–26615 CrossRef CAS PubMed.
  17. X. G. Si, Z. M. Zhang, C. G. Zheng, Z. T. Li and Q. Cai, Angew. Chem., Int. Ed., 2020, 59, 18412–18417 CrossRef CAS PubMed.
  18. M. M. Xu, L. M. Yang, K. Tan, X. Y. Chen, Q. T. Lu, K. N. Houk and Q. Cai, Nat. Catal., 2021, 4, 892–900 CrossRef CAS.
  19. G. H. Huang, C. Kouklovsky and A. de la Torre, Chem. Eur J., 2021, 27, 4760–4788 CrossRef CAS PubMed.
  20. G. H. Huang, C. Kouklovsky and A. de la Torre, J. Am. Chem. Soc., 2022, 144, 17803–17807 CrossRef CAS PubMed.
  21. Y. Wang, H. M. Li, Y. Q. Wang, Y. Liu, B. M. Foxman and L. Deng, J. Am. Chem. Soc., 2007, 129, 6364–6365 CrossRef CAS PubMed.
  22. F. Q. Zhang, B. T. Ren, Y. Q. Zhou, Y. B. Liu and X. M. Feng, Chem. Sci., 2022, 13, 5562–5567 RSC.
  23. H. B. Yu, Y. G. Chen, Y. Tian, M. S. Xie and H. M. Guo, ACS Catal., 2024, 14, 8930–8938 CrossRef CAS.
  24. A. M. Moiseev, E. S. Balenkova and V. G. Nenajdenko, Russ. Chem. Bull., 2006, 55, 712–717 CrossRef CAS.
  25. J. Nakayama, Bull. Chem. Soc. Jpn., 2000, 73, 1–17 CrossRef CAS.
  26. J. Nakayama, S. Yamaoka, T. Nakanishi and M. Hoshino, J. Am. Chem. Soc., 1988, 110, 6598–6599 CrossRef CAS.
  27. M. S. Raasch, J. Org. Chem., 1980, 45, 867–870 CrossRef CAS.
  28. D. B. Xia, X. Guo, L. Chen, M. Baumgarten, A. Keerthi and K. Müllen, Angew. Chem., Int. Ed., 2016, 55, 941–944 CrossRef CAS PubMed.
  29. D. Wang, C. X. Zhao, Y. M. Zhu, X. Y. Zhang, X. Y. Wang and P. An, Chem. Eur J., 2024, 30, e202402723 CrossRef CAS PubMed.
  30. B. R. Boswell, C. M. F. Mansson, G. E. Cabrera, C. R. Hansen, A. G. Oliver and N. Z. Burns, J. Am. Chem. Soc., 2023, 145, 5631–5636 CrossRef CAS PubMed.
  31. C. Niu, Y. Zhou, Q. Chen, Y. Zhu, S. Tang, Z. X. Yu and J. Sun, Org. Lett., 2022, 24, 7428–7433 CrossRef CAS PubMed.
  32. X. Y. Ji, E. M. El-Labbad, K. L. Ji, D. S. Lasheen, R. A. T. Serya, K. A. Abouzid and B. H. Wang, Org. Lett., 2017, 19, 818–821 CrossRef CAS PubMed.
  33. A. Kabuki and J. Yamaguchi, Synthesis, 2022, 54, 4963–4970 CrossRef CAS.
  34. K. H. K. Park, N. Frank, F. Duarte and E. A. Anderson, J. Am. Chem. Soc., 2022, 144, 10017–10024 CrossRef CAS PubMed.
  35. Z. S. Wang, S. H. Bennett, B. Kicin, C. C. Jing, J. A. Pradeilles, K. Thai, J. R. Smith, P. D. Bacos, V. Fasano, C. M. Saunders and V. K. Aggarwal, J. Am. Chem. Soc., 2023, 145, 14124–14132 CrossRef CAS PubMed.
  36. K. H. Park, J. Park, N. Frank, H. W. Zhang, P. L. Tian, Y. Biddick, F. Duarte and E. A. Anderson, Nat. Chem., 2026, 18, 782–789 CrossRef CAS PubMed.
  37. S. X. Feng, Q. T. Lu, Y. Lu, L. X. Cui, L. M. Yang, A. S. Baghel and Q. Cai, Angew. Chem., Int. Ed., 2025, 64, e202512345 CrossRef CAS PubMed.
  38. K. Narasaka, N. Iwasawa, M. Inoue, T. Yamada, M. Nakashima and J. Sugimori, J. Am. Chem. Soc., 1989, 111, 5340–5345 CrossRef CAS.
  39. K. Narasaka and I. Yamamoto, Tetrahedron, 1992, 48, 5743–5754 CrossRef CAS.
  40. K. V. Gothelf and K. A. Jorgensen, J. Org. Chem., 1995, 60, 6847–6851 CrossRef CAS.
  41. M. S. Andrä, J. Thiemermann, J. Schnaubelt, D. Lentz, R. Zimmer and H. U. Reissig, Eur. J. Org Chem., 2017, 124–130 CrossRef.
  42. D. Seebach, A. K. Beck and A. Heckel, Angew. Chem., Int. Ed., 2001, 40, 92–138 CrossRef CAS PubMed.
  43. M. Hou, M. M. Xu, B. C. Yang, H. B. He and S. H. Gao, Org. Lett., 2021, 23, 7487–7491 CrossRef CAS PubMed.
  44. K. Mikami, M. Terada, Y. Motoyama and T. Nakai, Tetrahedron:Asymmetry, 1991, 2, 643–646 CrossRef CAS.
  45. H. F. Du, J. Long, J. Y. Hu, X. Li and K. L. Ding, Org. Lett., 2002, 4, 4349–4352 CrossRef CAS.
  46. H. F. Du, X. Zhang, Z. Wang, H. L. Bao, T. P. You and K. L. Ding, Eur. J. Org Chem., 2008, 2248–2254 CrossRef CAS.
  47. G. Desimoni, G. Faita, M. Mella, F. Piccinini and M. Toscanini, Eur. J. Org Chem., 2007, 1529–1534 CrossRef CAS.
  48. G. H. Posner, H. Y. Dai, D. S. Bull, J. K. Lee, F. Eydoux, Y. Ishihara, W. Welsh, N. Pryor and S. Petr, J. Org. Chem., 1996, 61, 671–676 CrossRef CAS.
  49. J. Balsells, T. J. Davis, P. Carroll and P. J. Walsh, J. Am. Chem. Soc., 2002, 124, 10336–10348 CrossRef CAS PubMed.
  50. Y. Hayashi, N. Yamamura, T. Kusukawa and T. Harada, Chem. Eur J., 2016, 22, 12095–12105 CrossRef CAS PubMed.
  51. See the Supporting Information for details.
  52. Y. C. Lai, S. E. Mallakpour, G. B. Butler and G. J. Palenik, J. Org. Chem., 1985, 50, 4378–4381 CrossRef CAS.
  53. (a) CCDC 2512830: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2qbt1y; (b) CCDC 2512831: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2qbt2z.

Footnote

These authors contributed equally to this work.

This journal is © The Royal Society of Chemistry 2026
Click here to see how this site uses Cookies. View our privacy policy here.